메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
박찬권 (가톨릭의대부속여의도성모병원) 강지영 (가톨릭대학교)
저널정보
대한의학회 Journal of Korean Medical Science Journal of Korean Medical Science Vol.34 No.40
발행연도
2019.1
수록면
1 - 3 (3page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Mycobacterium tuberculosis (M.TB) infection in human immunodeficiency virus (HIV)-infected patients is one of the major opportunistic diseases, leading to severe morbidity and mortality. According to World Health Organization (WHO) tuberculosis (TB) reports,1 the number of patients with TB-HIV coinfection was 900,000 and the number of deaths was 300,000 in 2017. Comparing to the mortality rate of 16% due to TB in the general population, the percentage of deaths in TB-HIV patients was double at 33%. However, it is not easy to manage TB in immunocompromised hosts due to variable reasons: 1) vague symptoms related with TB, 2) low yields for microbiologic tests, 3) nontypical radiologic findings, 4) drug-drug interaction between anti-TB and anti-retroviral therapy (ART), 5) immune reconstitution inflammatory syndrome during the treatment, most of which are hurdles related with diagnosis. Therefore, the best strategy is to confirm and treat latent TB infection (LTBI), an early stage of TB infection that is characterized by a status of persistent immunity to M.TB antigen without manifestations of active disease, in HIV patients. Recently, WHO guidelines for LTBI2 also recommend that for adults living with HIV, LTBI should be treated in cases with unknown or a positive tuberculin skin test (TST) and without the evidence of active TB, irrespective of regional TB prevalence, the degree of immunosuppression, and use of ART

목차

등록된 정보가 없습니다.

참고문헌 (8)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0